<DOC>
	<DOCNO>NCT00239707</DOCNO>
	<brief_summary>The purpose study test safety glucose-dependent insulinotropic peptide ( GIP ) /GIP Analog people Type 2 Diabetes .</brief_summary>
	<brief_title>GIP : Glucose-dependent Insulinotropic Peptide</brief_title>
	<detailed_description>The small bowel make hormone call glucose-dependent insulinotropic peptide ( GIP ) . It release blood stream go pancreas . It work nutrient , especially glucose , digest food insulin release sufficient amount pancreas . The insulin cause nutrient food store liver , fat muscle need provide energy . GIP also slow empty food stomach , decrease rate fat food break store . Once release blood , GIP quickly break becomes inactive . Individuals type 2 diabetes make enough GIP pharmacological dos naturally occur GIP increase insulin secretion patient type 2 diabetes . This study test modify GIP ( one amino acid difference naturally occur human GIP ) break quickly individual type 2 diabetes , determine improve insulin secretion , eat , patient type 2 diabetes . The study also compare effect naturally occur , human GIP . Both human GIP modify GIP ( GIP analog ) manufacture peptide synthesis technique ( extract human gut recombinant technology ) . A screening visit perform include blood work , EKG physical exam . If eligible , patient would schedule three infusion visit 2 month apart , receive normal saline infusion first visit GIP GIP analog remain visit . The infusion visit begin approximately 6:45 a.m. patient frequent blood sample intravenous line period 7 hour . An additional intravenous line place infusion either normal saline , GIP GIP analog period 3 hour . Patients give breakfast meal consist 550 calorie ( one egg , piece toast margarine , corn flake 2 % milk banana ) . They give 2 Extra-Strength Tylenol determine time frame food empty stomach measure Tylenol level blood . At end study visit , patient give lunch , intravenous line discontinue discharge home .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>18 year age old Healthy Type 2 Diabetics Agree stay glucosidases 3 day prior infusion visit ( Examples : Precose , Glyset ) Agree stay Sulfonylureas 5 day prior infusion visit ( Examples : Glucotrol , Amaryl , glyburide , metformin Able ingest 1000 mg Tylenol study visit Able consume study breakfast consist scramble egg , white toast margarine , corn flake , 2 % milk , banana infusion visit Female participant must Hct &gt; 36 Male participant must Hct &gt; 38 No kidney liver disease per history evidence blood urine test Physical Exam EKG contraindicate patient study Taking follow medication : Insulin , Thiazolidinediones , i.e . Avandia , Actos Pregnancy Steroid use within past 3 month Recent infection , fever chill</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>insulin sensitivity</keyword>
	<keyword>blood sugar</keyword>
</DOC>